Objective: We aimed to describe sociodemographic, comorbidities, co-medication and risk of thromboembolic events and bleeding in patients with NVAF initiating oral anticoagulants (OAC) for stroke prevention, and to estimate adherence and persistence to OAC.
Setting: Primary Health Care (PHC) in the Catalan Health Institute (ICS), Catalunya, Spain.
Participants: All NVAF adult patients initiating OAC for stroke prevention in August 2013-December 2015.
Methods: Population-based cohort study. ...
Giner-Soriano, M. [et al.]. The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain: a real-world data cohort study. "Atención primaria", Octubre 2020, vol. 52, núm. 8, p. 529-538.